Overview
Sono-Tek reports fiscal Q2 revenue of $5.163, mln missing analysts' expectations
Net income for fiscal Q2 rises 24% yr/yr to $424,000, or $0.03 per share
Backlog increased 50% sequentially, driven by medical market orders
Outlook
Sono-Tek updates FY26 guidance, anticipating modest revenue growth
Company sees growing demand in medical device market as offset to clean energy uncertainties
Sono-Tek remains focused on execution amid evolving clean energy incentives and tariff policies
Result Drivers
MEDICAL MARKET GROWTH - Sales in the medical market increased 150% y-o-y, driven by balloon coating systems shipments
BACKLOG INCREASE - Backlog increased 50% sequentially, reflecting new order momentum from the medical market
GROSS PROFIT DRIVERS - Gross profit increased 3% y-o-y due to favorable product mix and reduced warranty expenses
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Slight Miss* | $5.16 mln | $5.20 mln (1 Analyst) |
Q2 EPS | Beat | $0.03 | $0.02 (2 Analysts) |
Q2 Net Income | $424,000 | ||
Q2 Gross Margin | 50% |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the industrial machinery & equipment peer group is "buy"
Wall Street's median 12-month price target for Sono-Tek Corp is $7.75, about 45.8% above its October 13 closing price of $4.20
The stock recently traded at 48 times the next 12-month earnings vs. a P/E of 64 three months ago
Press Release: ID:nGNXbGj6sD
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)